China Oriental : APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA ORIENTAL GROUP COMPANY LIMITED

中 國 東 方 集 團 控 股 有 限 公 司 *

（incorporated in Bermuda with limited liability）

（Stock code：581）

APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR

AND

COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES

The board of directors (the "Board") of China Oriental Group Company Limited (the "Company") hereby announces that Dr. Tse Cho Che, Edward ("Dr. Tse") has been appointed as an independent non-executive director of the Company ("INED") with effect from 7 November 2019.

The details of Dr. Tse as required under the Rule 13.51(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Stock Exchange") (the "Listing Rules") are set out below:

Dr. Tse Cho Che, Edward, aged 63, holds a bachelor's degree and a master's degree in civil engineering from the Massachusetts Institute of Technology, the United States, and a master of business administration as well as a Ph.D. in civil engineering from the University of California, Berkeley, the United States. Dr. Tse has been an independent non-executive director of China Travel International Investment Hong Kong Limited (listed on the main board of the Stock Exchange with stock code of 00308) since October 2018 and was an independent non-executive director of Shanghai Pharmaceuticals Holding Co., Ltd. (listed on the main board of the Stock Exchange and Shanghai Stock Exchange with stock code of 02607 and 601607 respectively) from June 2013 to June 2019. Dr. Tse has engaged in management consultancy and corporate senior management for over 30 years, with extensive experience and expertise in definition and implementation of corporate transformation, establishment of organizations, business strategy and overseas expansion. He holds the position of Chairman in Gao Feng Advisory Company since April 2014. He was the chairman in Greater China region of Booz & Company, an independent director of Baoshan Iron & Steel Co., Ltd. (listed on the main board of the Shanghai Stock Exchange with stock code 600019) from May 2006 to April 2012, outside director of Shanghai Automotive Industry Corporation (Group), executive vice president of corporate planning and development division and managing director of Greater China region of Cable & Wireless HKT Limited, a non-official member of the Strategy Development Commission and a part-time member of the Central Policy Unit of the Hong Kong Special Administrative Region Government, and managing partner of Greater China region of the Boston Consulting Group, etc..

1

Dr. Tse has entered into a service contract with the Company for a term of one year commencing from 7 November 2019 until the next annual general meeting of the Company, and subject to retirement by rotation and re-election in the said annual general meeting in accordance with the provisions as set out in the Company's bye-laws. The service contract may be terminated by either party by giving not less than three months' notice in writing. Dr. Tse will be entitled to HK$400,000 as emoluments per annum for acting as an INED, which was agreed upon mutual agreement with reference to the range of prevailing directors' fees for the directors of the Company and other listed companies in Hong Kong. The terms of appointment were approved by the Nomination Committee, the Remuneration Committee of the Company and the Board.

Save as disclosed above, as at the date of this announcement, (i) Dr. Tse does not have any interests in the shares or underlying shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong); (ii) Dr. Tse does not have any relationship with any other directors, senior management, substantial shareholders or controlling shareholders (as defined in the Listing Rules) of the Company; (iii) Dr. Tse does not hold any other positions in the Company or any of its subsidiaries; and (iv) Dr. Tse does not hold any other directorships in public listed companies, the securities of which are listed on any securities market in Hong Kong or overseas in the last three years preceding the date of this announcement.

Dr. Tse has met the independence guidelines set out in Rule 3.13 of the Listing Rules.

As confirmed by Dr. Tse and as far as the Board is aware, save as disclosed above, there are no any other matters which are required to be brought to the attention of the shareholders of the Company, or to be disclosed pursuant to the requirements under Rules 13.51(2)(h) to 13.51(2)(v) of the Listing Rules relating to the appointment of Dr. Tse as an INED.

The Board would like to extend its welcome to Dr. Tse in joining the Board.

COMPLIANCE WITH MINIMUM NUMBER OF INDEPENDENT NON-EXECUTIVE DIRECTORS

Following the appointment of Dr. Tse as an INED, the Board comprises eleven directors including six executive directors, one non-executive director and four INEDs. As the Board comprises at least one-third of the directors who are INEDs, the Company is in compliance with the requirement of the minimum number of independent non-executive directors prescribed under Rule 3.10A of the Listing Rules with effect from 7 November 2019.

By order of the Board

China Oriental Group Company Limited

HAN Jingyuan

Chairman and Chief Executive Officer

Hong Kong, 7 November 2019

2

As at the date of this announcement, the Board of Directors of the Company comprises Mr. HAN Jingyuan, Mr. ZHU Jun, Mr. SHEN Xiaoling, Mr. ZHU Hao, Mr. HAN Li and Mr. Sanjay SHARMA being the Executive Directors, Mr. Ondra OTRADOVEC being the Non-executive Director and Mr. WONG Man Chung, Francis, Mr. WANG Tianyi, Mr. WANG Bing and Dr. TSE Cho Che, Edward being the Independent Non-executive Directors.

This announcement is published on the websites of the Company (www.chinaorientalgroup.com) and The Stock Exchange of Hong Kong Limited (www.hkexnews.hk).

*For identification purposes only

3